arrow_back Back to App

Ending Misleading Prescription Drug Ads

This act aims to ensure that prescription drug advertisements on TV and radio present key information clearly and understandably. If the government doesn't issue its own rules, previously proposed regulations will automatically take effect. This will provide citizens with more reliable information about medications, helping them make informed health decisions.
Key points
Prescription drug ads on TV and radio must clearly present important information.
If new rules aren't established, older proposals will become law automatically.
The goal is to protect consumers from misleading drug advertisements.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8289
Sponsor: Rep. Spanberger, Abigail Davis [D-VA-7]
Process start date: 2022-07-05
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Banning Misleading Drug Ads Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8289.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-05.

What are the main provisions?

Key points include:

  • Prescription drug ads on TV and radio must clearly present important information.
  • If new rules aren't established, older proposals will become law automatically.
  • The goal is to protect consumers from misleading drug advertisements.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Spanberger, Abigail Davis [D-VA-7].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health